Skip to main content
Journal cover image

Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B.

Publication ,  Journal Article
van Velsen, LM; Patmore, LA; Feld, JJ; Chan, HLY; Piratvisuth, T; Chien, R-N; Dongelmans, EJ; Pavlovic, V; Yee, LJ; Brouwer, WP; Lau, A ...
Published in: Clin Gastroenterol Hepatol
January 2026

BACKGROUND & AIMS: The presence of metabolic comorbidities is associated with a higher risk of liver-related events in chronic hepatitis B (CHB) patients. However, the association between presence of metabolic comorbidities and the severity of biopsy-proven liver fibrosis is yet unknown. METHODS: Data from CHB patients from 2 tertiary clinics and 8 clinical trials was analyzed. We studied the association between presence of metabolic comorbidities with severity of liver fibrosis in untreated patients, and with fibrosis regression or progression in biopsies taken after initiation of antiviral therapy. RESULTS: We analyzed biopsies from 3179 untreated CHB patients. Median age was 37 years, 57.6% were hepatitis B e antigen positive, with median hepatitis B virus DNA of 7.30 logIU/mL. Overweight (29.4% vs 19.0%; P < .001), hypertension (40.7% vs 23.2%; P < .001), diabetes (42.2% vs 23.6%; P < .001), and dyslipidemia (42.9 vs 23.6%; P < .001) were associated with a higher risk of advanced fibrosis, with the highest risk observed in patients with multiple comorbidities. Findings were consistent in multivariable analysis (1 comorbidity: adjusted odds ratio [aOR], 1.115; ≥2 comorbidities: aOR, 1.627; P = .006). Regression to nonadvanced fibrosis, after treatment initiation, was more often observed in patients without metabolic comorbidities (43.1%), compared with patients with 1 (31.6%) or ≥2 comorbidities (17.0%) (P = .005). Findings were consistent in multivariable analysis (1 comorbidity: aOR, 0.792; ≥2 comorbidities: aOR, 0.260; P = .025). The risk of progression to advanced fibrosis was highest in patients with ≥2 comorbidities (14.3% vs 4.6%; P = .001). CONCLUSIONS: Presence of metabolic comorbidities in untreated CHB patients is associated with more severe liver fibrosis and, after initiation of antiviral therapy, with less fibrosis regression and a higher risk of fibrosis progression.

Duke Scholars

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

January 2026

Volume

24

Issue

1

Start / End Page

121 / 130.e12

Location

United States

Related Subject Headings

  • Young Adult
  • Severity of Illness Index
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Humans
  • Hepatitis B, Chronic
  • Gastroenterology & Hepatology
  • Female
  • Disease Progression
 

Citation

APA
Chicago
ICMJE
MLA
NLM
van Velsen, L. M., Patmore, L. A., Feld, J. J., Chan, H. L. Y., Piratvisuth, T., Chien, R.-N., … SONIC-B study group. (2026). Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol, 24(1), 121-130.e12. https://doi.org/10.1016/j.cgh.2025.04.024
Velsen, Lisa M. van, Lesley A. Patmore, Jordan J. Feld, Henry L. Y. Chan, Teerha Piratvisuth, Rong-Nan Chien, Edo J. Dongelmans, et al. “Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B.Clin Gastroenterol Hepatol 24, no. 1 (January 2026): 121-130.e12. https://doi.org/10.1016/j.cgh.2025.04.024.
van Velsen LM, Patmore LA, Feld JJ, Chan HLY, Piratvisuth T, Chien R-N, et al. Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2026 Jan;24(1):121-130.e12.
van Velsen, Lisa M., et al. “Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B.Clin Gastroenterol Hepatol, vol. 24, no. 1, Jan. 2026, pp. 121-130.e12. Pubmed, doi:10.1016/j.cgh.2025.04.024.
van Velsen LM, Patmore LA, Feld JJ, Chan HLY, Piratvisuth T, Chien R-N, Dongelmans EJ, Pavlovic V, Yee LJ, Brouwer WP, Lau A, Hansen BE, Buti M, Xie Q, Patel K, Fung SK, Janssen HLA, Sonneveld MJ, SONIC-B study group. Association of Metabolic Comorbidities With Fibrosis Severity and Fibrosis Regression in Patients With Chronic Hepatitis B. Clin Gastroenterol Hepatol. 2026 Jan;24(1):121-130.e12.
Journal cover image

Published In

Clin Gastroenterol Hepatol

DOI

EISSN

1542-7714

Publication Date

January 2026

Volume

24

Issue

1

Start / End Page

121 / 130.e12

Location

United States

Related Subject Headings

  • Young Adult
  • Severity of Illness Index
  • Middle Aged
  • Male
  • Liver Cirrhosis
  • Humans
  • Hepatitis B, Chronic
  • Gastroenterology & Hepatology
  • Female
  • Disease Progression